An Act to create 49.45 (49m) (e) and 632.854 of the statutes; Relating to: coverage of nonopioid drug alternatives for the treatment and management of pain.
Impact
If enacted, SB492 will significantly impact state laws by expanding insurance coverage for nonopioid medications. This legislative move is expected to alleviate the burden on patients seeking alternatives to opioids, potentially reducing dependency on these highly regulated substances. By mandating insurance providers to cover these alternatives, the bill aims to align state healthcare policies with contemporary medical practices that prioritize patient safety and wellness.
Summary
SB492 proposes to ensure coverage for nonopioid drug alternatives for the treatment and management of pain. This initiative arises in response to the ongoing opioid crisis, aiming to provide patients and healthcare providers with alternatives that minimize the risks associated with opioid use. The bill seeks to enhance the availability of nonopioid medications as safe options for managing pain, fostering a more holistic healthcare approach.
Contention
The discussions surrounding SB492 have highlighted notable points of contention among stakeholders, particularly regarding the adequate formulation and approval of nonopioid alternatives. Critics express concerns about the effectiveness and safety of nonopioid medications, questioning whether they can truly serve as viable alternatives to established treatments. Additionally, the financial implications for insurance providers and potential pushback from pharmaceutical companies have emerged as key areas of debate, reflecting the complexities of healthcare reforms in response to the opioid epidemic.
Crossfiled
An Act to create 49.45 (49m) (e) and 632.854 of the statutes; Relating to: coverage of nonopioid drug alternatives for the treatment and management of pain.
Requires insurers to develop plans for coverage and access to nonnarcotic, nonopioid and nonmedication pain management for moderate to severe pain. It further restricts utilization review for nonopioid drugs.
A bill for an act establishing a veterans recovery pilot program and fund for the reimbursement of expenses related to providing hyperbaric oxygen treatment to eligible veterans and making appropriations.(Formerly HF 326.)
A bill for an act establishing a veterans recovery pilot program and fund for the reimbursement of expenses related to providing hyperbaric oxygen treatment to eligible veterans and making appropriations.(See HF 518.)